Myocardial Ischemia Without Obstructive Coronary Stenoses
Launched by HOSPITAL SAN CARLOS, MADRID · Mar 30, 2021
Trial Information
Current as of August 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a condition called myocardial ischemia, which is when the heart doesn't get enough blood flow, but the cause is not due to a blockage in the main heart arteries. Instead, it explores issues like problems with small blood vessels or unusual reactions in blood flow. The goal is to gain a better understanding of these non-blocking heart problems, which can affect many people.
To participate in this trial, you need to be at least 18 years old and give written consent. You should be eligible for specific heart tests that involve medications like adenosine or acetylcholine. However, this trial is not for everyone—people who have certain heart issues, serious health problems, or who cannot take these medications will not be able to join. If you participate, you can expect to undergo some tests to help researchers learn more about your heart's condition. Overall, this trial aims to shed light on heart issues that don’t involve traditional blockages, helping to improve understanding and treatment options for those affected.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Written informed consent available.
- • Age ≥ 18 years.
- • Patient eligible for invasive physiological assessment with adenosine and / or acetylcholine.
- Exclusion Criteria:
- • Hemodynamic instability.
- • Anticipated technical issues for physiology wire measurements.
- • Culprit vessel of acute coronary syndrome
- • Contraindications for adenosine administration.
- • Contraindications for acetylcholine test.
- • Reduced life expectancy (less than 1 year).
About Hospital San Carlos, Madrid
Hospital San Carlos, located in Madrid, is a leading healthcare institution renowned for its commitment to advancing medical research and improving patient outcomes. As a prominent clinical trial sponsor, the hospital is dedicated to conducting innovative studies that adhere to the highest ethical and scientific standards. With a multidisciplinary team of experienced researchers and clinicians, Hospital San Carlos aims to explore novel therapeutic approaches and contribute to the development of cutting-edge treatments across various medical fields. Its strategic collaborations and robust infrastructure enable the hospital to effectively facilitate clinical trials, ultimately enhancing the quality of care provided to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Patients applied
Trial Officials
Hernan Mejia-Renteria, MD, PhD
Principal Investigator
Department of Cardiology, Hospital Clinico San Carlos
Javier Escaned, MD, PhD
Principal Investigator
Department of Cardiology, Hospital Clinico San Carlos
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials